Changes in cervical cytokine profiles following focused ultrasound treatment for high‐risk human papillomavirus infection–related low‐grade cervical lesions

Abstract

AbstractObjectiveTo evaluate the changes of cervical soluble immune markers after focused ultrasound (FU) treatment to explore the underlying local immune effects of FU in the treatment of high‐risk human papillomavirus (HR‐HPV) infection–related low‐grade squamous intraepithelial lesion (LSIL).MethodsA total of 35 patients diagnosed with HR‐HPV infection–related histological LSIL who met the inclusion criteria were enrolled in this prospective study and treated with FU. The authors used cytometric bead array to measure T‐helper type 1 (Th1) cytokine (interleukin [IL] 2, tumor necrosis factor, and interferon γ) and Th2 cytokine (IL‐4, IL‐5, IL‐6, and IL‐10) levels in the cervicovaginal lavage of patients before and 3 months after FU treatment.ResultsAfter FU treatment, the concentrations of Th2 cytokines IL‐5 and IL‐6 were significantly lower than those before FU treatment (P = 0.044 and P = 0.028, respectively). HR‐HPV infection was cleared in 27 patients, with a clearance rate of 77.1% (27 of 35). The concentration of IL‐4 in patients with HR‐HPV clearance after FU treatment was significantly lower than that in patients without HR‐HPV clearance (P = 0.045).ConclusionFU can inhibit the production of certain Th2 cytokines and may improve the local immune status of the cervix, thereby eliminating HR‐HPV infection.